SMNROTCPharmaceutical PreparationsFiscal year ends December 31Also trades as SMNRW
Semnur Pharmaceuticals, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$0.43+0.03 (+6.75%)
Close on Oct 19, 2026
- Market cap
- $98.30M
- P/E (TTM)
- –
- Dividend yield
- –
Community
Notes and questions about Semnur Pharmaceuticals from other investors
No posts about SMNR yet
Discussion opens with sign-in. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.